Popular race course basic frequency now clearing risk of closing "unbundle" stimulating fund redemption.

The reporter noticed that, as the industry index continued to rise, several leading performance pharmaceutical funds, military industry funds, and new consumption funds are facing a significant redemption pressure after the net asset value is unlocked. Some innovative drug funds with impressive performance are not willing to liquidate directly. Therefore, they have called for a holder meeting to seek modifications to the termination clause of the fund contract in order to preserve the existence of the fund product. This highlights the increasing divergence in various investment strategies in the booming stock fund market. The reporter noted that most of the funds facing termination risks or liquidation due to redemption pressure are high-quality track funds with high market popularity and good performance this year. These funds have achieved good returns and rankings, with their net asset values approaching or just completing the unwinding process.